Financial Data and Key Metrics Changes - In Q4 2025, revenue reached $304 million, growing 24% year-over-year and 12% organically, with full-year revenue increasing 17% to $1.1 billion [21][22] - Adjusted EBITDA for Q4 was $129 million, up 29% year-over-year, with an adjusted EBITDA margin of 42.5%, exceeding the long-term target of 40% [10][24] - Unlevered free cash flow was $80 million in Q4 and $365 million for the full year, converting 79% of adjusted EBITDA to unlevered free cash flow [25] Business Line Data and Key Metrics Changes - Subscription revenue for Q4 was $168 million, increasing 38% year-over-year, while volume-based revenue was $134 million, up 11% year-over-year [23] - For the full year, subscription revenue totaled $558 million, a 22% increase, and volume-based revenue reached $535 million, also up 11% year-over-year [24] Market Data and Key Metrics Changes - Waystar added 85 clients with trailing twelve-month spend above $100,000 in Q4, a 16% year-over-year increase, with a net revenue retention rate of 112% [9][22] - The company processed over 7 billion transactions annually, touching approximately 60% of the U.S. patient population each year [17] Company Strategy and Development Direction - The acquisition of Iodine Software expanded Waystar's addressable market and client base, adding over 1,000 hospitals and health systems [7][11] - Waystar aims to lead in AI-powered revenue cycle automation, with approximately 50% of its solutions leveraging AI [14][20] - The company is focused on delivering a fully autonomous revenue cycle, integrating clinical and financial data to enhance operational efficiency [12][87] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the durability of their business model, expecting normalized organic growth of approximately 10% for 2026 [26] - The company anticipates continued healthy patient utilization and strong demand for its platform, which is expected to insulate it from reimbursement rate pressures [26][66] Other Important Information - The company expects to realize over 90% of committed cost synergies from the Iodine acquisition in fiscal 2026 [11][29] - Waystar's commercial model aligns with consumption, directly matching how value is created in the revenue cycle [15] Q&A Session Summary Question: Customer appetite for AI integration - Management noted that most clients prefer to integrate AI capabilities into their existing systems rather than build their own, highlighting the importance of a trusted partner [41] Question: Incremental revenue opportunities from new AI agents - New AI agents are expected to provide both incremental revenue opportunities and enhance the existing AI offerings, contributing to client retention and value [43][44] Question: Impact of Iodine on margins and cost centers - The increase in G&A, R&D, and SG&A costs is attributed to the full quarter contribution from Iodine, with expectations for continued margin improvement through cost synergies [48][49] Question: AI market growth in healthcare - Management sees significant opportunities in AI within healthcare, emphasizing the need for secure, scalable, and accurate solutions [60][62] Question: Patient healthcare utilization assumptions - The company expects patient utilization to remain healthy, projecting growth above the historical baseline of 1%-2% [66] Question: Trends in patient deductible timelines - Management observed a decrease in patient volumes as patients hit their deductibles, but this was offset by growth in provider solutions [70][71] Question: Competitive landscape and ROI - Management highlighted robust win rates and the importance of a platform approach, which is increasingly preferred by clients over point solutions [83][84]

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Dive Brief: Tenet has regained full ownership of Conifer Health Solutions, acquiring the remaining stake in its revenue cycle management business from CommonSpirit Health. CommonSpirit will pay Tenet almost $1.9 billion over the next three years to get out of its existing services contract, according to the deal announced Monday. That’s offset by $540 milli ...

J.P. MORGAN CONFERENCE Waystar Overview January 12, 2026 ADMIN ACCOUNT ANALYTICS PATIENT TOOLS Executive Dashboard Enaces Explore 32 4.82% Average Days to Pay Denial Rate ▼ 5.3% Previous Month Change ▼ -21% Previous Month Change Payment Trend May Apri NESCH February Recelved Manth Denial Rate Trend Summary March April May June July Received Month WAYSTAR FORWARD-LOOKING STATEMENTS This presentation contains forvard looking statements, within the meaning of the Private Securities Litigstion Reform Act of P99 ...

Financial Data and Key Metrics Changes - The company reported a standalone growth rate of 8% year-over-year for Q4, indicating strength in the business [48] - Revenue mix is approximately 50% subscription and 50% volume-based, allowing the company to capture upside from increased utilization [18] Business Line Data and Key Metrics Changes - The company is seeing significant demand for multiple sales solutions and platform-type opportunities, particularly as clients seek to reduce the number of vendors in their ecosystem [15][16] - The acquisition of Iodine is expected to enhance the company's ability to submit "perfect undeniable claims," improving the overall claims process [10][12] Market Data and Key Metrics Changes - The company has a total addressable market opportunity of over $17 billion, with low penetration in the high single digits [43] - Utilization has been strong, with continued patient engagement leading to increased revenue opportunities for healthcare providers [18] Company Strategy and Development Direction - The company aims to build, buy, or partner in the digital front door market to enhance patient engagement and revenue capture [44] - There is a focus on autonomous coding as a means to improve efficiency and accuracy in claims processing [45] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in maintaining long-term low double-digit revenue growth and strong free cash flow conversion [51] - The company is cautiously optimistic about the future, with no immediate changes expected in growth expectations [51] Other Important Information - The company has a high gross revenue retention rate of 97% and typically sees annual price increases of 3-4% [24] - The generative AI solutions have shown significant early reception, with clients reporting a 70% decrease in prior authorization times and a 90% reduction in time for denials and appeals management [21][22] Q&A Session Summary Question: How has the sales cycle shaped up this year versus prior years? - Management noted strong activity in the pipeline and demand for multiple sales solutions, particularly from health systems and hospitals [14][17] Question: Can you discuss the impact of AI on your technology stack? - The company highlighted the integration of over 160 AI modules from Iodine, which enhance the processing of unstructured data into clinical codes [13] Question: What is the competitive dynamic in the market? - Management emphasized the differentiation in ROI and client experience compared to legacy competitors and new entrants, highlighting the importance of a high-touch client experience [29][30] Question: What are the future opportunities for growth? - The company is exploring opportunities in the digital front door market and autonomous coding, aiming to address client pain points and enhance service offerings [44][45]

As filed with the U.S. Securities and Exchange Commission November 26, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 DIGITALALLY, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Nevada 3663 20-0064269 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) Digital Ally, Inc. 63 ...

Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 As filed with the U.S. Securities and Exchange Commission November 26, 2025 DIGITALALLY, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Nevada 3663 20-0064269 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) Digital Ally, Inc. 63 ...

As filed with the Securities and Exchange Commission on January 24, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 DIGITALALLY, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Nevada 3663 20-0064269 (Primary Standard Industrial Classification Code Number) (IRS Employer Identification No.) 14001 Marshall Drive Lenexa, K ...